Taking your company public through an IPO is a crucial step, presenting a unique opportunity to benefit both your business and its investors. Explore the Nasdaq IPO Academy, a program tailored to ...
Clinical-stage biopharmaceutical company Aardvark Therapeutics (AARD) priced its IPO of ~5.89M shares at $16.00 per share. All of the shares are being offered by Aardvark. The California-based startup ...
NEW YORK and TOKYO, Feb. 18, 2025 (GLOBE NEWSWIRE) -- HeartCore Enterprises, Inc. (Nasdaq: HTCR) (“HeartCore” or “the Company”), a leading enterprise software and data consulting services company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback